Latest Methylation Stories
Japanese and U.S. scientists in the young field of epigenetics Thursday reported a rationale as to how specific genes are silenced and others are not.
Mayo Clinic researchers have discovered two mutations responsible for a devastating neurological condition they first identified 15 years ago.
Exposure to air pollution early in life and when a woman gives birth to her first child may alter her DNA and may be associated with premenopausal breast cancer later in life, researchers at the University at Buffalo have shown.
BellBrook Labs has developed a new HTS assay for screening methyltransferases, the family of enzymes involved in epigenetic modifications that cause cancerous cell growth and metastasis.
A newly sequenced bacterial genome from a team led by the Department of Energy's Oak Ridge National Laboratory (ORNL) could contain clues as to how microorganisms produce a highly toxic form of mercury.
SAN DIEGO, April 8, 2011 /PRNewswire/ -- Polaris Group (Polaris) announced today that data from preclinical studies suggest ADI-PEG 20, the Company's pegylated arginine deiminase therapeutic, may be effective in treating acute myeloid leukemia (AML), glioblastoma multiforme (GBM) and bladder cancer.
IPSWICH, Mass. and SAN DIEGO, April 5, 2011 /PRNewswire/ -- New England Biolabs, Inc. (NEB) and Sequenom, Inc. (NASDAQ: SQNM) jointly announce that they have signed a licensing and co-marketing agreement to commercialize research tools for epigenetics.
When the Human Genome Project ended a decade ago, scientists thought that they'd closed the lid on all that's to be known about our genes.
A blood test may be able to accurately detect markers of bladder cancer.
Reprogramming adult cells to recapture their youthful "can-do-it-all" attitude appears to leave an indelible mark, found researchers at the Salk Institute for Biological Studies.
- A political dynamiter.